doi: 10.3389/fddev.2024.1456654 Received 28 June 2024 Accepted 14 October 2024 Published 06 November 2024 Volume 4 - 2024 Edited by Rakesh Patel, Shree S K Patel College of Pharmaceutical Education and Research Ganpat University, India Reviewed by Fiona McCartney, University College Dublin, Ireland Samar ISSA, cole de Biologie Industrielle, France Updates Copyright 2024 New, Bogus, Travers, Hahn, Vaiceliunaite, Burnet, Wang and Wen
The seven-day half-life is consistent enough across populations that it reliably supports weekly dosing for nearly everyone
Polymorphic regulation of membrane lipid composition Nature 1987
AMP-activated protein kinase signaling is upregulated in papillary thyroid cancer
Incorrect dosage of non-FDA-approved fat-dissolving injections can also lead to infections or scarring
Actual replacements